# name
Securing sustainable funding for viral hepatitis elimination plans

# metadata.dc.description.abstract[].value
The majority of people infected with chronic hepatitis C
                virus (HCV) in the European Union (EU) remain undiagnosed and
                untreated. During recent years, immigration to EU has further
                increased HCV prevalence. It has been estimated that, out of the
                4.2 million adults affected by HCV infection in the 31 EU/
                European Economic Area (EEA) countries, as many as
                580\xC2\xA0000 are migrants. Additionally, HCV is highly
                prevalent and under addressed in Eastern Europe. In 2013, the
                introduction of highly effective treatments for HCV with
                direct-acting antivirals created an unprecedented opportunity to
                cure almost all patients, reduce HCV transmission and eliminate
                the disease. However, in many settings, HCV elimination poses a
                serious challenge for countries' health spending. On 6 June
                2018, the Hepatitis B and C Public Policy Association held the
                2nd EU HCV Policy summit. It was emphasized that key
                stakeholders should work collaboratively since only a few
                countries in the EU are on track to achieve HCV elimination by
                2030. In particular, more effort is needed for universal
                screening. The micro-elimination approach in specific
                populations is less complex and less costly than country-wide
                elimination programmes and is an important first step in many
                settings. Preliminary data suggest that implementation of the
                World Health Organization (WHO) Global Health Sector Strategy on
                Viral Hepatitis can be cost saving. However, innovative
                financing mechanisms are needed to raise funds upfront for
                scaling up screening, treatment and harm reduction interventions
                that can lead to HCV elimination by 2030, the stated goal of the
                WHO.

# metadata.dc.source[].value
Articles publicats en revistes (ISGlobal)

# metadata.dc.title[].value
Securing sustainable funding for viral hepatitis elimination plans